Azt-PMAP is utilized primarily in the field of medical research, particularly in studies related to antiviral therapies for HIV. It is known for its potential role in inhibiting the reverse transcriptase enzyme in HIV virus, thereby suppressing viral replication and serving as a key step in developing anti-HIV drugs. Researchers explore its efficacy in targeting specific viral mechanisms, testing the performance and safety of new compounds. Additionally, studies assess its toxicity and impact on normal cells to ensure its potential as a future therapeutic agent. It may be used in combination with other compounds to improve its antiviral properties or reduce resistance. Its application extends to laboratory experiments where it serves as a tool to understand viral behavior and test new drug formulations.